JEROME SCOTT HARMS

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells
    Jerome S Harms
    Department of Animal Health and Biomedical Sciences, University of Wisconsin Madison, Madison, WI 53706 1581, USA
    Genet Vaccines Ther 2:11. 2004
  2. pmc Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella
    Jerome S Harms
    Department of Pathobiological Sciences, University of Wisconsin Madison, 1656 Linden Drive, Madison, WI 53706, USA
    J Immune Based Ther Vaccines 7:1. 2009

Detail Information

Publications2

  1. pmc Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells
    Jerome S Harms
    Department of Animal Health and Biomedical Sciences, University of Wisconsin Madison, Madison, WI 53706 1581, USA
    Genet Vaccines Ther 2:11. 2004
    ..In contrast, the non-specific activator, TSA, enhanced both BLVp and CMVp activity. CONCLUSION: Based on these data, we conclude the BLV promoter could be very useful for transgene expression in mammalian expression vectors...
  2. pmc Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella
    Jerome S Harms
    Department of Pathobiological Sciences, University of Wisconsin Madison, 1656 Linden Drive, Madison, WI 53706, USA
    J Immune Based Ther Vaccines 7:1. 2009
    ..In this study, we evaluate an approach using a live, non-pathogenic bacteria (E. coli) genetically engineered to mimic the brucellae pathway of infection and present antigens for an appropriate cytolitic T cell response...